期刊文献+

恶性肿瘤患者发生VTE的相关危险因素及风险评估模型的研究进展

Research Progress on Risk Factors and Risk Assessment Models for VTE in Malignant Tumor Patients
下载PDF
导出
摘要 总结恶性肿瘤并发静脉血栓栓塞症的危险因素以及相关静脉血栓风险评估模型,并对风险评估工具的基本特征、应用优缺点进行分析,旨在为今后开发符合中国国情及恶性肿瘤患者群体特征的静脉血栓风险评估模型与临床应用提供依据。 Summarize the risk factors and related venous thromboembolism risk assessment models for ma-lignant tumors, and analyze the basic characteristics and advantages and disadvantages of risk as-sessment tools. The aim is to provide a basis for the future development of venous thromboembo-lism risk assessment models and clinical applications that are in line with China’s national condi-tions and the characteristics of malignant tumor patient populations.
出处 《临床医学进展》 2024年第1期971-978,共8页 Advances in Clinical Medicine
  • 相关文献

参考文献1

二级参考文献104

  • 1Alexander T Cohen,Bruce L Davidson,Alexander S Gallus,Michael R Lassen,Martin H Prins,Witold Tomkowski,Alexander G G Turpie,Jan F M Egberts,Anthonie W A Lensing,石汉平(译),王深明(校).Fondaparinux预防老年急性内科患者发生静脉血栓形成的效果与安全性:随机安慰剂对照研究[J].英国医学杂志中文版,2006,9(5):282-285. 被引量:4
  • 2Kryssia I. Rodriguez‐Castro,Paolo Simioni,Patrizia Burra,Marco Senzolo.Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis[J].Liver Int.2012(10)
  • 3Marco Senzolo,Teresa M. Sartori,Valeria Rossetto,Patrizia Burra,Umberto Cillo,Patrizia Boccagni,Daniele Gasparini,Diego Miotto,Paolo Simioni,Emmanuel Tsochatzis,Kenneth A. Burroughs.Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis[J].Liver Int.2012(6)
  • 4Maria Assunta Zocco,Enrico Di Stasio,Raimondo De Cristofaro,Marialuisa Novi,Maria Elena Ainora,Francesca Ponziani,Laura Riccardi,Stefano Lancellotti,Angelo Santoliquido,Roberto Flore,Maurizio Pompili,Gian Lodovico Rapaccini,Paolo Tondi,Giovanni Battista Gasbarrini,Raffaele Landolfi,Antonio Gasbarrini.Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development[J].Journal of Hepatology.2009(4)
  • 5A. A.KHORANA,C. W.FRANCIS,E.CULAKOVA,N. M.KUDERER,G. H.LYMAN.Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy[J]. Journal of Thrombosis and Haemostasis . 2007 (3)
  • 6Agnes Y.Y Lee.Epidemiology and management of venous thromboembolism in patients with cancer[J]. Thrombosis Research . 2003 (4)
  • 7Simon IR Noble,Mike D Shelley,Bernadette Coles,Susan M Williams,Andrew Wilcock,Miriam J Johnson.Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis[J]. Lancet Oncology . 2008 (6)
  • 8Giancarlo Agnelli,Giorgio Bolis,Lorenzo Capussotti,Roberto Mario Scarpa,Francesco Tonelli,Erminio Bonizzoni,Marco Moia,Fabio Parazzini,Romina Rossi,Francesco Sonaglia,Bettina Valarani,Carlo Bianchini,Gualberto Gussoni.A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery: The @RISTOS Project[J]. Annals of Surgery . 2006 (1)
  • 9Dominique-Charles Valla,Bertrand Condat.Portal vein thrombosis in adults: pathophysiology, pathogenesis and management[J]. Journal of Hepatology . 2000 (5)
  • 10Schulman Sam,Kearon Clive,Kakkar Ajay K,Schellong Sebastian,Eriksson Henry,Baanstra David,Kvamme Anne Mathilde,Friedman Jeffrey,Mismetti Patrick,Goldhaber Samuel Z.Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. The New England Quarterly . 2013

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部